Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme. Issue 4 (April 2020)
- Record Type:
- Journal Article
- Title:
- Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme. Issue 4 (April 2020)
- Main Title:
- Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme
- Authors:
- Mancini, Silvia
Bucchi, Lauro
Giuliani, Orietta
Ravaioli, Alessandra
Vattiato, Rosa
Baldacchini, Flavia
Ferretti, Stefano
Sassoli de Bianchi, Priscilla
Mezzetti, Francesca
Triossi, Omero
Serafini, Monica
Ricci, Enrico
Palazzi, Mauro
Imolesi, Claudia
Giovanardi, Mauro
Canuti, Debora
Voci, Claudio
Altini, Mattia
Falcini, Fabio - Abstract:
- Abstract: Background: The European guidelines for quality assurance in colorectal cancer (CRC) screening recommend that interval cancer rate be expressed as a proportion of background incidence rate. Aim: To determine the crude and adjusted proportional incidence of interval CRC in an Italian regional two-yearly faecal immunochemical test (FIT) screening programme. Methods: The programme (year of implementation, 2005) is targeted at over 1, 000, 000 people aged 50–69 years. The test is a one-sample OC-Sensor (Eiken Chemical Co., Tokyo, Japan). The study covered one-third of the regional area. Excerpts of 434, 295 eligible negative FIT records dated 2005–2012 from 193, 193 subjects were retrieved from the regional CRC screening data warehouse. By 31 December 2013, the cohort accumulated 198, 302 man-years and 235, 370 woman-years. Interval CRCs were identified by record-linkage with the local population-based cancer registry. Their number was divided by the expected number, estimated with age-period-cohort models, to obtain the proportional incidence. Results: The proportional incidence of interval CRC for men and women was, respectively, 0.06 (95% confidence interval (CI), 0.04–0.09) and 0.17 (95% CI, 0.13–0.23) in the first interval year, and 0.21 (95% CI, 0.16–0.26) and 0.28 (95% CI, 0.22–0.36) in the second year. Conclusions: The results were acceptable and in line with previous studies.
- Is Part Of:
- Digestive and liver disease. Volume 52:Issue 4(2020)
- Journal:
- Digestive and liver disease
- Issue:
- Volume 52:Issue 4(2020)
- Issue Display:
- Volume 52, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 52
- Issue:
- 4
- Issue Sort Value:
- 2020-0052-0004-0000
- Page Start:
- 452
- Page End:
- 456
- Publication Date:
- 2020-04
- Subjects:
- Colorectal cancer -- Faecal immunochemical test -- Screening -- Sensitivity
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dld.2020.02.007 ↗
- Languages:
- English
- ISSNs:
- 1590-8658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13437.xml